Home > Healthcare > Breast Cancer Diagnostics Market > Table of Contents

Breast Cancer Diagnostics Market – By Product (Instruments, Kits & Consumables), Test Type (Imaging, Biopsy, Genomic Test, Blood Test), Cancer Type (Ductal Carcinoma in Situ, Invasive Ductal Carcinoma), Application, End-use - Global Forecast 2024 – 2032

  • Report ID: GMI10383
  • Published Date: Jul 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Growing prevalence of breast cancer globally

3.2.1.2    Technological advancements in breast cancer diagnostics

3.2.1.3    Rising government initiatives and awareness programs

3.2.2    Industry pitfalls & challenges

3.2.2.1    High cost of diagnostic tests

3.2.2.2    Stringent regulatory scenario

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Technology landscape

3.5.1    Core technologies

3.5.2    Adjacent technologies

3.6    Future market trends

3.7    Gap analysis

3.8    Porter’s analysis

3.9    PESTLE analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Company matrix analysis

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Instruments

5.3    Kits and consumables

Chapter 6   Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Imaging

6.2.1    Mammography

6.2.2    MRI

6.2.3    Ultrasound

6.2.4    PET/CT

6.3    Biopsy

6.4    Genomic tests

6.5    Blood tests

6.6    Other test types

Chapter 7   Market Estimates and Forecast, By Cancer Type, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Ductal carcinoma in situ

7.3    Invasive ductal carcinoma

7.4    Inflammatory breast cancer

7.5    Metastatic breast cancer

Chapter 8   Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    Screening

8.3    Diagnostic and predictive

8.4    Prognostic

8.5    Research

Chapter 9   Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)

9.1    Key trends

9.2    Hospitals and clinics

9.3    Diagnostic centers

9.4    Cancer research institutes

9.5    Other end-users

Chapter 10   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

10.1    Key trends

10.2    North America

10.2.1   U.S.

10.2.2   Canada

10.3    Europe

10.3.1   Germany

10.3.2   UK

10.3.3   France

10.3.4   Spain

10.3.5   Italy

10.3.6   Netherlands

10.3.7   Rest of Europe

10.4    Asia Pacific

10.4.1   China

10.4.2   Japan

10.4.3   India

10.4.4   Australia

10.4.5   South Korea

10.4.6   Rest of Asia Pacific

10.5    Latin America

10.5.1   Brazil

10.5.2   Mexico

10.5.3   Argentina

10.5.4   Rest of Latin America

10.6    Middle East and Africa

10.6.1   South Africa

10.6.2   Saudi Arabia

10.6.3   UAE

10.6.4   Rest of Middle East and Africa

Chapter 11   Company Profiles

11.1    Argon Medical Devices

11.2    Becton, Dickinson and Company

11.3    Bio-Rad Laboratories, Inc.

11.4    Canon Inc.

11.5    Danaher Corporation

11.6    Exact Sciences Corporation

11.7    F. Hoffmann-La Roche Ltd

11.8    FUJIFILM Holdings Corporation

11.9    Hologic, Inc.

11.10    Illumina, Inc.

11.11    Koninklijke Philips N.V.

11.12    Myriad Genetics, Inc.

11.13    QIAGEN N.V.

11.14    Siemens Healthineers AG

11.15    Thermo Fisher Scientific Inc.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 413
  • Countries covered: 23
  • Pages: 208
 Download Free Sample